Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 03-1992 | 12-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 1,275,817 | N/A | 928,423 | 778,460 |
| Depreciation Amortization | N/A | 695,336 | N/A | 591,134 | 520,687 |
| Other Working Capital | N/A | -655,307 | N/A | -549,686 | 277,248 |
| Other Operating Activity | 0 | 15,419 | 0 | 201,666 | -61,959 |
| Operating Cash Flow | $N/A | $1,331,265 | $N/A | $1,171,537 | $1,514,436 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2,147,148 | N/A | -1,556,290 | -1,235,032 |
| Other Investing Activity | 0 | 2,147,148 | 0 | -1,474,730 | 119,529 |
| Investing Cash Flow | $N/A | $0 | $N/A | $-3,031,020 | $-1,115,503 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | -146,405 | N/A | -125,705 | -125,505 |
| Other Financing Activity | 0 | 536,781 | 0 | 1,903,398 | -86,736 |
| Financing Cash Flow | $N/A | $390,376 | $N/A | $1,777,693 | $-212,241 |
| Exchange Rate Effect | N/A | 0 | N/A | -4,347 | -36,750 |
| Beginning Cash Position | N/A | 0 | N/A | 639,573 | 489,631 |
| End Cash Position | N/A | 0 | N/A | 553,436 | 639,573 |
| Net Cash Flow | $N/A | $0 | $N/A | $-86,137 | $149,942 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 1,331,265 | N/A | 1,171,537 | 1,514,436 |
| Free Cash Flow | 0 | 1,331,265 | 0 | 1,171,537 | 1,514,436 |